These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 29462633

  • 1. Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.
    Battini S, Mannava MKC, Nangia A.
    J Pharm Sci; 2018 Jun; 107(6):1667-1679. PubMed ID: 29462633
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Stability of isoniazid, rifampin and pyrazinamide in suspensions used for the treatment of tuberculosis in children.
    Seifart HI, Parkin DP, Donald PR.
    Pediatr Infect Dis J; 1991 Nov; 10(11):827-31. PubMed ID: 1749695
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG, Lötter AP.
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract] [Full Text] [Related]

  • 7. Compatibility Between Four Anti-TB Drugs and Tablet Excipients Determined By Microcalorimetry.
    Aucamp M, Liebenberg W, Okaecwe T, Geldenhuys M, Stieger N.
    Pharmazie; 2019 Jun 01; 74(6):350-351. PubMed ID: 31138372
    [Abstract] [Full Text] [Related]

  • 8. Tackling quantitative polymorphic analysis through fixed-dose combination tablets production. Pyrazinamide polymorphic assessment.
    Antonio M, Raffaghelli M, Maggio RM.
    J Pharm Biomed Anal; 2021 Feb 05; 194():113786. PubMed ID: 33281002
    [Abstract] [Full Text] [Related]

  • 9. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP, Ebrahim S, Pillay V.
    Int J Tuberc Lung Dis; 2003 Mar 05; 7(3):289-97. PubMed ID: 12661846
    [Abstract] [Full Text] [Related]

  • 10. Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.
    Almeida D, Nuermberger E, Tasneen R, Rosenthal I, Tyagi S, Williams K, Peloquin C, Grosset J.
    Antimicrob Agents Chemother; 2009 Oct 05; 53(10):4178-84. PubMed ID: 19620331
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ascorbic acid improves stability and pharmacokinetics of rifampicin in the presence of isoniazid.
    Rajaram S, Vemuri VD, Natham R.
    J Pharm Biomed Anal; 2014 Nov 05; 100():103-108. PubMed ID: 25151231
    [Abstract] [Full Text] [Related]

  • 16. Behavior of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and the presence of light. 1. Pure anti-tuberculosis drugs and their combinations.
    Singh S, Bhutani H, Mariappan TT, Kaur H, Bajaj M, Pakhale S.
    Int J Pharm; 2002 Oct 01; 245(1-2):37-44. PubMed ID: 12270240
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Entrapment of multiple anti-Tb drugs in microemulsion system: quantitative analysis, stability, and in vitro release studies.
    Mehta SK, Kaur G, Bhasin KK.
    J Pharm Sci; 2010 Apr 01; 99(4):1896-911. PubMed ID: 19894276
    [Abstract] [Full Text] [Related]

  • 19. Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.
    Singh H, Bhandari R, Kaur IP.
    Int J Pharm; 2013 Mar 25; 446(1-2):106-11. PubMed ID: 23410991
    [Abstract] [Full Text] [Related]

  • 20. Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity.
    Tostmann A, Boeree MJ, Peters WH, Roelofs HM, Aarnoutse RE, van der Ven AJ, Dekhuijzen PN.
    Int J Antimicrob Agents; 2008 Jun 25; 31(6):577-80. PubMed ID: 18358703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.